Craft

Alnylam Pharmaceuticals

Stock Price

$153.9

2024-06-18

Market Capitalization

$19.5 B

2024-06-18

Revenue

$1.8 B

FY, 2023

Alnylam Pharmaceuticals Summary

Company Summary

Overview
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The Company’s pipeline focuses in three strategic therapeutic areas (STArs): genetic medicines, with a pipeline of RNAi therapeutics for the treatment of rare diseases; cardio-metabolic disease, with a pipeline of RNAi therapeutics toward genetically validated, liver-expressed disease in cardiovascular and metabolic diseases, and hepatic infectious disease, with a pipeline of RNAi therapeutics for treatment of hepatic infectious diseases.
Type
Public
Status
Active
Founded
2002
HQ
Cambridge, MA, US | view all locations
Website
http://www.alnylam.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Yvonne Greenstreet

    Yvonne Greenstreet, Chief Executive Officer, Director

  • Pushkal Garg

    Pushkal Garg, Chief Medical Officer and EVP, Development & Medical Affairs

  • Laurie Keating

    Laurie Keating, Chair of the Board of Directors

  • Jeff Poulton

    Jeff Poulton, Chief Financial Officer

LocationsView all

9 locations detected

  • Cambridge, MA HQ

    United States

    675 W Kendall St

  • Taunton, MA

    United States

    20 Commerce Way

  • Paris, IDF

    France

    100 Av. de Suffren

  • Milan, Lombardia

    Italy

    Via Pola, 11

  • Tokyo, Tokyo

    Japan

    11th Floor of Pacific Century Place Marunouchi 1-11-1 Marunouchi, Chiyoda-ku

  • Amsterdam, NH

    Netherlands

    Cross Towers, 20e verdieping Antonio Vivaldistraat 150

and 3 others

Alnylam Pharmaceuticals Financials

Summary Financials

Revenue (Q1, 2024)
$494.3M
Gross profit (Q1, 2024)
$439.7M
Net income (Q1, 2024)
($65.9M)
Cash (Q1, 2024)
$681.9M
EBIT (Q1, 2024)
($43.4M)
Enterprise value
$19.8B

Footer menu